Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMD NASDAQ:BIOL NASDAQ:BJDX NASDAQ:BLAC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$0.73-5.4%$1.26$0.60▼$8.44$1.90M1.921.16 million shs569,292 shsBIOLBIOLASE$0.01$0.02▼$1.94$581K0.672.58 million shsN/ABJDXBluejay Diagnostics$1.54-1.9%$1.49$1.26▼$12.45$2.30M0.481.30 million shs92,403 shsBLACBellevue Life Sciences Acquisition$0.62+1.7%$0.82$3.01▼$13.40$2.51M-0.0822,626 shs201,288 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%+7.09%-32.18%-57.04%-74.83%BIOLBIOLASE0.00%0.00%0.00%-90.74%-98.12%BJDXBluejay Diagnostics0.00%+8.28%+15.44%-6.55%-79.25%BLACBellevue Life Sciences Acquisition0.00%+7.84%+10.52%-56.02%-94.32%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$0.73-5.4%$1.26$0.60▼$8.44$1.90M1.921.16 million shs569,292 shsBIOLBIOLASE$0.01$0.02▼$1.94$581K0.672.58 million shsN/ABJDXBluejay Diagnostics$1.54-1.9%$1.49$1.26▼$12.45$2.30M0.481.30 million shs92,403 shsBLACBellevue Life Sciences Acquisition$0.62+1.7%$0.82$3.01▼$13.40$2.51M-0.0822,626 shs201,288 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%+7.09%-32.18%-57.04%-74.83%BIOLBIOLASE0.00%0.00%0.00%-90.74%-98.12%BJDXBluejay Diagnostics0.00%+8.28%+15.44%-6.55%-79.25%BLACBellevue Life Sciences Acquisition0.00%+7.84%+10.52%-56.02%-94.32%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 2.00Hold$56.007,559.69% UpsideBIOLBIOLASE 3.00Buy$0.40∞ UpsideBJDXBluejay Diagnostics 0.00N/AN/AN/ABLACBellevue Life Sciences Acquisition 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BIOL, BLAC, BJDX, and AEMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/14/2025AEMDAethlon MedicalHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral7/7/2025AEMDAethlon MedicalHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon MedicalN/AN/AN/AN/A$2.55 per shareN/ABIOLBIOLASE$48.83M0.00N/AN/A($0.07) per share0.00BJDXBluejay Diagnostics$250K9.18N/AN/A$10.34 per share0.15BLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$13.39M-$12.64N/AN/AN/AN/A-266.21%-179.46%11/12/2025 (Estimated)BIOLBIOLASE-$20.63M-$14.94N/AN/AN/A-41.65%-1,782.73%-55.31%N/ABJDXBluejay Diagnostics-$7.72M-$125.15N/A∞N/AN/A-362.07%-299.10%N/ABLACBellevue Life Sciences AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ALatest BIOL, BLAC, BJDX, and AEMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q1 2026AEMDAethlon Medical-$0.68-$0.85-$0.17-$0.85N/AN/A8/7/2025Q2 2025BJDXBluejay DiagnosticsN/A-$1.41N/A-$1.41N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/ABIOLBIOLASEN/AN/AN/AN/AN/ABJDXBluejay DiagnosticsN/AN/AN/AN/AN/ABLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A2.492.49BIOLBIOLASEN/A0.710.36BJDXBluejay DiagnosticsN/A4.564.56BLACBellevue Life Sciences AcquisitionN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%BIOLBIOLASE8.79%BJDXBluejay Diagnostics18.47%BLACBellevue Life Sciences Acquisition55.30%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical1.20%BIOLBIOLASE0.27%BJDXBluejay Diagnostics0.08%BLACBellevue Life Sciences Acquisition33.67%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical102.60 million2.57 millionNo DataBIOLBIOLASE16033.41 million33.32 millionNot OptionableBJDXBluejay Diagnostics91.49 million1.49 millionNot OptionableBLACBellevue Life Sciences AcquisitionN/A4.04 million2.68 millionNot OptionableBIOL, BLAC, BJDX, and AEMD HeadlinesRecent News About These CompaniesOSR Holdings CoFebruary 13, 2025 | vir.com.vnVBellevue Life Sciences Acquisition CorpFebruary 13, 2025 | vir.com.vnVBellevue Life Sciences Acquisition Corp Announces Approval of Business Combination Proposal And Name Change to OSR Holdings IncFebruary 13, 2025 | msn.comOSR Holdings set to trade on Nasdaq after mergerFebruary 13, 2025 | msn.comBellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc.February 13, 2025 | finance.yahoo.com(BLAC) On The My Stocks PageFebruary 13, 2025 | news.stocktradersdaily.comNBLAC stock touches 52-week low at $6.3 amid market challengesFebruary 12, 2025 | msn.comBellevue Life Sciences stock hits 52-week low at $7February 11, 2025 | msn.comHow the (BLAC) price action is used to our AdvantageFebruary 2, 2025 | news.stocktradersdaily.comNBLACU Bellevue Life Sciences Acquisition Corp. UnitsJanuary 29, 2025 | seekingalpha.comBellevue Life Sciences extends promissory note maturityJanuary 24, 2025 | msn.comHow to Take Advantage of moves in (BLAC)January 1, 2025 | news.stocktradersdaily.comN(BLAC) Trading ReportDecember 12, 2024 | news.stocktradersdaily.comNBellevue Life Sciences Acquisition Corp trading halted, volatility trading pauseNovember 15, 2024 | markets.businessinsider.comBellevue Life Sciences Acquisition Corp trading resumesNovember 15, 2024 | markets.businessinsider.com(BLAC) Trading SignalsOctober 9, 2024 | news.stocktradersdaily.comNBellevue Life Sciences Acquisition (BLAC)September 20, 2024 | investing.comPharmaLegacy acquires BTS Research in hopes of becoming a 'highly competitive global CRO'September 16, 2024 | fiercebiotech.comFBellevue video game company faces class-action lawsuit over antitrust practicesAugust 14, 2024 | bizjournals.comBellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder MeetingMay 13, 2024 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBIOL, BLAC, BJDX, and AEMD Company DescriptionsAethlon Medical NASDAQ:AEMD$0.73 -0.04 (-5.44%) Closing price 04:00 PM EasternExtended Trading$0.73 -0.01 (-0.70%) As of 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.BIOLASE NASDAQ:BIOLBIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.Bluejay Diagnostics NASDAQ:BJDX$1.54 -0.03 (-1.91%) Closing price 04:00 PM EasternExtended Trading$1.50 -0.04 (-2.27%) As of 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.Bellevue Life Sciences Acquisition NASDAQ:BLAC$0.62 +0.01 (+1.66%) As of 09/12/2025Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Royal Caribbean's 33% Dividend Hike Signals Deeper Growth MarketBeat Week in Review – 09/08 - 09/12 Adobe’s Rebound Has Room to Run: 25% Upside by Year-End Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
